TITLE

HUMAN PAPILLOMAVIRUS IN THE ETIOLOGY OF HEAD AND NECK CARCINOMAS

AUTHOR(S)
Michl, Petr; Pazdera, Jindrich; Prochazka, Martin; Pink, Richard; Stosova, Tatana
PUB. DATE
March 2010
SOURCE
Biomedical Papers of the Medical Faculty of Palacky University i;2010, Vol. 154 Issue 1, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. For more than 20 years, infection with the human papillomavirus (HPV) has been of a matter of interest not only to gynecologists but also to maxillofacial surgeons and othorhinolaryngologists. HPV is generally known to be involved in cervical cancer. Recently, there are many clinical studies pointed out the potentially dangerous connection between HPV infection and head and neck carcinomas (HNC). HPV infection was identified as a possible etiological factor in 15-30% of HNC. Methods. Aim of this article is to summarize the recent knowledge about the HPV infection with regards to etiology of head and neck cancer. Results. It has been proven that HPV infection is related to development of head and neck cancer and that the sexual behavior has played an important role in the viral transmission. HNC of viral etiology have been observed mostly in younger people; their curability is difficult and prognosis serious. Conclusion. Beside the well known correlation between developing of new head and neck cancer and bad habits (smoking, alcohol abuse, poor oral hygiene etc.) we should take into consideration the sexual promiscuity and alternative sexual practices. Vaccination against cervical cancer, recommended to young women, should be extended to their male partners to prevent the virus transmission and decrease the HNC incidence.
ACCESSION #
51642472

 

Related Articles

  • Optimizing approaches to head-and-neck cancersViruses in head-and-neck cancers: prevention and therapy. Psyrri, A.; Tsiodras, S. // Annals of Oncology;Sep2008 Supplement 7, Vol. 19, p189 

    The article offers information on the development of preventive and therapeutic strategies designed to reduce the incidence and mortality of Human Papillomaviruses (HPVs)-associated head-and-neck cancers. It states that Surveillance, Epidemiology and End Results (SEER) data showed that the...

  • Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. Harris, M; Wang, X G; Jiang, Z; Phaeton, R; Koba, W; Goldberg, G L; Casadevall, A; Dadachova, E // British Journal of Cancer;3/5/2013, Vol. 108 Issue 4, p859 

    Background:Human papilloma virus (HPV) is implicated in >99% of cervical cancers and ∼40% of head and neck squamous cell carcinoma (HNSCC). We previously targeted E6 oncogene with 188Rhenium-labelled monoclonal antibody (mAb) C1P5 to HPV16 E6 in cervical cancer and HNSCC. Intranuclear E6...

  • PREVENÇÃO DO CANCRO DO COLO DO ÚTERO. dos Santos, Carla Alves // Onco.news;primavera2010, Issue 12, p14 

    Cervical cancer has a major impact on the lives of women worldwide. Although cancer is common in the elderly, cervical cancer mainly affects young women, between 35 and 50, many with work and family responsibilities. In the European Union, about 34,000 new cases and 16,000 deaths from cervical...

  • Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis. Abogunrin, Seye; Di Tanna, Gian Luca; Keeping, Sam; Carroll, Stuart; Iheanacho, Ike // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Infection with human papillomavirus (HPV) is necessary for the development of cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies, such as head and neck cancers, is less well characterised. This study aimed to address key information gaps by...

  • Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Hocking, J. S.; Stein, A.; Conway, E. L.; Regan, D.; Grulich, A.; Law, M.; Brotherton, J. M. L. // British Journal of Cancer;3/1/2011, Vol. 104 Issue 5, p886 

    Background:Although tobacco- and alcohol-associated head and neck cancers are declining in the developed world, potentially human papillomavirus (HPV)-associated oropharnygeal cancers are increasing.Methods:We analysed oropharyngeal and oral cavity cancer rates in Australia in 1982-2005. Cancers...

  • Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available? Porta, M.; González, B.; Márquez, S.; Artazcoz, I. // Journal of Epidemiology & Community Health;Aug2008, Vol. 62 Issue 8, p667 

    The article focuses on the doubts related to the suitability of the universal human papillomavirus (HPV) vaccination. The authors state that policy makers must rigorously evaluate the benefits of HPV vaccine before deciding on specific bills related to it. In Spain, there have ben doubts...

  • Cervarix PI updated.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p48 

    The article offers information on the product information (PI) of the Cervarix human papillomavirus (HPV) vaccine, which was shown as highly effective against cervical pre-cancerous lesions caused by HPV types 16 and 18.

  • Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan. Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang // BMC Health Services Research;2010, Vol. 10, Special section p1 

    Background: Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited data available describing the...

  • Cancer vaccinations begin.  // Australian Nursing Journal;May2007, Vol. 14 Issue 10, p14 

    The article provides information on the National Human Papillomavirus Vaccination (HPV) program in Australia. The aim of the program is to vaccinate girls against cervical cancer. The government has provided $537 million for the program and the HPV vaccine is being provided through school-based...

  • Variations of the Cervical Internal Carotid Artery. Metgudmath, Rajendra; Metgudmath, Anjali; Metgudmath, Vinita; Jainkeri, Vivek // Indian Journal of Otolaryngology & Head & Neck Surgery;Jul-Sep2013, Vol. 65 Issue 3, p210 

    The objective of this study was to report the variations of the cervical internal carotid artery, as encountered during neck dissection for head and neck malignancies. A retrospective analysis of neck dissections performed for the management of various head and neck cancers, during 2006-2010 was...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics